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Protein surface accessible residues play an important role in protein folding, protein-protein
interactions and protein-ligand binding. However, a common problem associated with the use
of selective chemical labeling methods for mapping protein solvent accessible residues is that
when a complicated peptide mixture resulting from a large protein or protein complex is
analyzed, the modified peptides may be difficult to identify and characterize amongst the
largely unmodified peptide population (i.e., the ‘needle in a haystack’ problem). To address
this challenge, we describe here the development of a strategy involving the synthesis and
application of a novel ‘fixed charge’ sulfonium ion containing lysine-specific protein modifi-
cation reagent, S,S’-dimethylthiobutanoylhydroxysuccinimide ester (DMBNHS), coupled with
capillary HPLC-ESI-MS, automated CID-MS/MS, and data-dependant neutral loss mode MS3
in an ion trap mass spectrometer, to map the surface accessible lysine residues in a small model
protein, cellular retinoic acid binding protein II (CRABP II). After reaction with different
reagent:protein ratios and digestion with Glu-C, modified peptides are selectively identified
and the number of modifications within each peptide are determined by CID-MS/MS, via the
exclusive neutral loss(es) of dimethylsulfide, independently of the amino acid composition and
precursor ion charge state (i.e., proton mobility) of the peptide. The observation of these
characteristic neutral losses are then used to automatically ‘trigger’ the acquisition of an MS3
spectrum to allow the peptide sequence and the site(s) of modification to be characterized. Using
this approach, the experimentally determined relative solvent accessibilities of the lysine residues
were found to show good agreement with the known solution structure of CRABP II. (J Am Soc
Mass Spectrom 2010, 21, 1339–1351) © 2010 American Society for Mass SpectrometryMass spectrometry (MS) combined with proteinlabeling has found increasing utility as an alter-native tool to conventional high-resolution
methods such as X-ray crystallography or NMR for
the examination of higher order protein structure
(e.g., tertiary and quaternary), conformation, ligand
binding, and dynamics [1]. Although typically provid-
ing lower resolution than these more established ap-
proaches, MS-based analysis strategies have particular
advantages in sensitivity and speed, and the capability
of analyzing proteins or protein complexes that are not
amenable to crystallization, or that fall outside the mass
range routinely accessible by NMR.
A variety of MS/protein labeling methods have been
developed, and are based on either the use of (1)
hydrogen-deuterium exchange (HDX) [2, 3] or (2) stable
chemical modification [4–6], before proteolytic diges-
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spectrometry (MS/MS). HDX may potentially be used
to probe the entire protein backbone, thereby providing
the highest resolution of the MS-based approaches.
However, limitations of HDX that can hamper determi-
nation of the precise location of exchange sites and
therefore limit the spatial resolution that can be ob-
tained, are the back-exchange of deuterium to hydrogen
during proteolysis and sample handling before MS
analysis [7, 8], and hydrogen/deuterium ‘scrambling’
during CID-MS/MS analysis [9]. Recently, the latter
problem has been largely overcome by the use of
alternate dissociation techniques such as electron cap-
ture dissociation (ECD) [10] and electron-transfer dis-
sociation (ETD) during MS/MS [11].
Stable chemical labeling strategies have included (1)
nonspecific oxidative modification of protein side-chain
functional groups induced by hydroxyl radicals formed
via the radiolysis of water by synchrotron X-ray pulses
[4], or by photolysis of H2O2 using pulsed UV lasers [5],
and (2) specific labeling [6] or cross-linking [12] of
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a protein of interest. For both approaches, the reactivity
of individual amino acid side chains within the protein
of interest is highly dependent on their degree of
exposure (i.e., ‘accessibility’) to the solvent environ-
ment. Protein solvent accessible amino acid residues
have significant biological importance, since they are
often intimately involved in protein folding and in
protein-protein or protein-ligand interactions. Thus, the
use of these methods can provide detailed information
for de novo protein structure analysis, or provide
constraints to structural modeling efforts directed to-
ward proteins not amenable to X-ray crystallography or
NMR.
A particular advantage of oxidative radical labeling
approaches is that the reaction typically occurs in a time
scale faster than that for protein unfolding, thereby
allowing the dynamics of protein conformational
changes to be examined [4]. It has been demonstrated
that all 20 amino acids plus cystine can be oxidized by
hydroxyl radicals, potentially providing high spatial
resolution. However, the resultant mass spectra may be
complicated and difficult to interpret due to the wide
variety of oxidative products that can be formed [13].
Hydroxyl radical reactions may also lead to cleavage of
peptide bonds, cleavage or ring opening of amino acid
side chains, or the formation of protein cross-links.
Moreover, when the oxidation sites are distributed
randomly among several surface amino acid residues,
the concentration of each oxidized peptide may be too
low to detect [14]. There is also a concern that extensive
oxidation may alter a protein’s native conformation,
thereby leading to erroneous results [15–17].
Despite the potential loss of spatial resolution, chem-
ical labeling methods that specifically target a particular
functional group or amino acid side chain have some
advantages over nonspecific labeling methods in terms
of the accessibility of the chemical reagents (i.e., access
to pulsed X-ray or UV laser sources is not required), the
ability to use protein “friendly” conditions during the
modification process, and the simplicity of the resultant
mass spectra [4]. Lysine is one of the most widely
targeted amino acids for chemical modification because
it is usually located at protein surfaces due to the
presence of its positively charged polar side chain
under physiological pH conditions. Consequently, ly-
sine residues are often involved in protein-protein or
protein-ligand interactions [18–22]. Acetic anhydride
was the earliest lysine derivatization reagent used [18].
More recently, however, lysine targeted labeling strat-
egies have shifted towards the use of N-hydroxysuccin-
imide (NHS) esters, due to their improved reaction
specificity and a roughly 1000-fold lower required con-
centration compared with acetic anhydride [22–26].
Lysine-specific modification by S-methylthioacetimi-
date has also been recently reported [27]. The resultant
amidine has a positive charge at physiological pH, a
feature that mimics the native lysine side chain and
therefore may serve to minimize labeling induced alter-ations in protein conformation. The positive charge also
increases the ionization efficiency of modified peptides,
thereby improving the sensitivity and sequence cover-
age obtainable by mass spectrometry. Despite the dem-
onstrated benefits of these specific chemical labeling
methods for mapping protein solvent accessible resi-
dues, a common problem is that when a complicated
peptide mixture resulting from a large protein or pro-
tein complex is analyzed, the modified peptides may be
difficult to detect amongst the largely unmodified pep-
tide population, i.e., constituting a ‘needle in a hay-
stack’ problem.
To overcome this problem, we have developed a
chemical derivatization and multistage MS/MS (MSn)
based analysis strategy, involving the introduction of a
‘fixed-charge’ sulfonium ion to peptides or proteins
containing certain structural features (e.g., the side
chains of selected amino acids such as methionine
[28–31], or cysteine [32], or within a cross-linking
reagent targeting lysine residues [33]. CID-MS/MS of
these peptide ions results in the exclusive loss of a
dialkylsulfide moiety from the modified side chain
under low-energy CID-MS/MS conditions, indepen-
dently of the amino acid composition and precursor ion
charge state (i.e., proton mobility) of the peptide [34–
37]. Therefore, derivatized peptides can be readily iden-
tified from within complex mixtures by using auto-
mated selective neutral loss or precursor ion scan mode
MS/MS methods, without requirement for purification
or otherwise enrichment before analysis. Based on the
results obtained from previous studies of sulfonium ion
derivatized peptide ions, an expected increase in selec-
tivity and sensitivity of one to two orders of magnitude
over conventional MS based approaches can be
achieved, due to the reduction in chemical noise asso-
ciated with the MS/MS experiment [28, 31]. Further
structural interrogation of identified peptide ions is
readily achieved by subjecting the characteristic
MS/MS product ion to multistage MS/MS (MS3 in a
quadrupole ion trap mass spectrometer, or by energy
resolved ‘pseudo’ MS3 in a triple quadrupole mass
spectrometer). Furthermore, the incorporation of ‘light’
and ‘heavy’ isotopically encoded labels into the fixed-
charge derivatives has also enabled the extension of this
approach to the differential quantitative analysis of
peptide abundances, via measurement of the relative
abundances of the neutral loss product ions generated
by dissociation of the light and heavy labeled peptide
ions [28, 31].
Here, as an initial step toward extending this strat-
egy toward the improved analysis of higher order
protein structures, we describe the synthesis, character-
ization, and initial application of an amine-specific
sulfonium ion containing protein modification reagent,
S,S’-dimethylthiobutanoylhydroxysuccinimide ester
[DMBNHS (1)] using a model protein, human cellular
retinoic acid binding protein II (CRABP II) [38].
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Materials
Sodium methanethiolate, -butyrolactone, tris
(hydroxymethyl)aminomethane (Tris), and guanidine
hydrochloride were purchased from Sigma-Aldrich (St.
Louis,MO, USA). Anhydrous dimethyl sulfoxide (DMSO)
(stored over 3Å sieves), N-hydroxysuccinimide (NHS)
and N,N=-dicyclohexylcarbodiimide (DCC) were from
Fluka (Buchs, Switzerland). HCl and NaCl were pur-
chased from Columbus Chemical Industries (Columbus,
WI, USA). Diethyl ether, KCl, Dimethylformamide
(DMF), and Silica gel (200–425 mesh) were from Jade
Scientific (Canton, MI, USA). Chloroform, dichlo-
romethane (DCM), and ethyl acetate were from
Mallinckrodt Chemicals (Phillipsburg, NJ, USA). Ace-
tonitrile (CH3CN) and iodomethane were purchased
from EMD Chemicals (San Diego, CA, USA).
Na2HPO4 · 7H2O and KH2PO4 were from Spectrum
Chemical Mfg. (Gardena, CA, USA). Endoprotease
Glu-C was purchased from Thermo Fisher Scientific
(Waltham, MA, USA). All aqueous solutions were pre-
pared using deionized water obtained from a Barnstead
nanopure diamond purification system (Dubuque, IA,
USA). CRABP II was supplied by Dr. Babak Borhan
(Department of Chemistry, Michigan State University).
Synthesis and Characterization of Protein
Modification Reagent
The synthesis of the amine-specific protein modification
reagent, DMBNHS (1) was achieved via a three-step
process as described below.
Synthesis of Methylthiobutyric Acid (2)
Based on the method of Williams et al. [39], sodium
methanethiolate (6.97 g, 99.5 mmol) and -butyrolactone
(4.46 mL, 74.63 mmol) were dissolved in 90 mL of
anhydrous DMSO, and then the solution was stirred
under N2 atmosphere at room temperature for 6 d; 166
mL of 1M HCl was added to the resulting slurry, and
then the aqueous solution was extracted with 6  104
mL of diethyl ether. The solvent was evaporated under
reduced pressure. The crude product was purified by
silica gel column chromatography (100% ethyl acetate)
to give 5.97 g (yield 60%) product as a colorless oil. 1H
NMR (500 MHz, CDCl3):  1.90 (m, 2H, J  7), 2.07 (s,
3H), 2.47 (t, 2H, J  7), 2.52 (t, 2H, J  7.5), 11.15 (s, 1H).
Synthesis of Methylthiobutyric
Hydroxysuccinimide Ester (3)
Under a N2 atmosphere, NHS (3.80 g, 33 mmol) and (2)
(4.02 g, 30 mmol) were dissolved in a mixture of CHCl3
(60 mL) and CH2Cl2 (30 mL). The mixture was stirred
for 5 min at room temperature. Then DCC (6.80 g, 33mmol) was added and a precipitate formed immedi-
ately. The resulting suspension was stirred in N2 atmo-
sphere for 24 h. The mixture was then filtered and the
filtrate was collected and concentrated under reduced
pressure. Five mL of CH3CN was then added to the
residue and the resulting precipitate was filtered out.
The resultant solution was dried in vacuo, after which
6.08 g (88%) of product was obtained as a white solid.
1H NMR (500MHz, CDCl3):  2.02 (m, 2H, J  7.5), 2.09
(s, 3H), 2.59 (t, 2H, J  7), 2.75 (t, 2H, J  7), 2.82 (s, 4H).
Synthesis of DMBNHS Iodide (1)
(3) (0.231 g, 1 mmol) and iodomethane (0.71 g, 5 mmol)
were dissolved in 2 mL of CH3CN followed by stirring
in the dark at room temperature for 2 d. The resulting
solution was then concentrated under reduced pres-
sure. The resultant yellow solid was washed with 10 mL
of DCM then dried in vacuo to give 0.28 g (76%)
product as yellow crystals. The product was stored in
the dark. 1H NMR (500MHz, CD3CN):  2.16 (m, 2H, J 
7.5), 2.77 (s, 4H), 2.81 (s, 6H), 2.85 (t, 2H, J  7.5), 3.29 (t,
3H, J  7.5). Mass spectrometric analysis was also
performed to further confirm the structure and gas-
phase fragmentation behavior of DMBNHS (1).
Characterization by NMR and MS
1H NMR spectra were performed on a Varian Innovo
500 MHz instrument and recorded in parts per million
(ppm) referenced to the solvent resonances (), with
coupling constants (J) in hertz (Hz). MS analysis was
performed on a Thermo Scientific model LCQ Deca 3D
quadrupole ion trap (San Jose, CA, USA) equipped with
nanospray ESI (nESI) as the ionization source. Samples
(20 M) were introduced at a flow rate of 2 L min1.
The spray voltage was set at 2.5 kV and the capillary
temperature was maintained at 150 °C. CID-MS/MS
experiments were performed using standard isolation
and activation conditions. MS of singly charged
DMBNHS (1) revealed a single ion at m/z 246.0
corresponding to [DMBNHS]. CID-MS/MS of the
[DMBNHS] ion gave rise to a dominant product ion
at m/z 184.0 corresponding to the dominant neutral loss
of S(CH3)2 (data not shown).
Protein Modification
CRABP II (25 g, 1.60 nmol) was suspended in 100 L
of PBS buffer (NaCl: 136.75 mM, Na2HPO4 · 7H2O: 8.10
mM, KCl: 2.68 mM, KH2PO4: 1.47 mM). One L of
DMBNHS solution dissolved in DMF with concentra-
tions of 8.0 mM (CRABP II : DMBNHS  1:5), 16 mM
(CRABP II : DMBNHS  1:10), 32 mM (CRABP II :
DMBNHS  1:20), 80 mM (CRABP II : DMBNHS 
1:50), and 160 mM (CRABP II : DMBNHS  1:100) were
added and each of them was incubated at room tem-
perature for 30 min. The reaction was immediately
quenched by addition of a 160-fold molar excess of Tris
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by vacuum centrifugation. 25 L of PBS buffer contain-
ing 6 M guanidine hydrochloride was then added and
the protein was denatured at 37 °C for 1 h. Two
hundred twenty-five L of ddH2O was added to bring
the final volume to 250 L. Five L of 0.25 g/L
Glu-C solution [Glu-C:CRABP II  1:20(wt/wt)] was
added and the reaction mixture was incubated at 31°C
in a water bath overnight. The digestion was quenched
by adding 3 L of formic acid and diluted 5-fold to 1.6
pmol/L with 3% acetic acid/5% CH3CN before
HPLC-MS analysis.
HPLC-ESI-MS, CID-MS/MS and -MS3 for
Protein Analysis
LC-MS, -MS/MS, and -MS3 analyses were performed
using a Thermo LTQ linear quadrupole ion trap mass
spectrometer (Thermo, San Jose, CA, USA) equipped
with an Advance nESI source and Paradigm MS4 cap-
illary RP-HPLC system (Michrom Bioresources, Au-
burn, CA, USA). Analyses were performed using auto-
mated methods created by the Xcalibur software
(Thermo, San Jose, CA, USA). Samples were injected
from a Paradigm AS1 autosampler (Michrom Biore-
sources, Auburn, CA, USA) onto a 200 m i.d. 50 mm
fused silica column packed with Magic C18 (3 m;
Michrom Bioresources, Auburn, CA, USA) at a flow
rate of 2 L min1. Peptides were eluted using a linear
45 min gradient from 95% solvent A (0.1% formic acid
in H2O) to 50% Solvent B (0.1% formic acid in CH3CN).
The ion transfer tube of the mass spectrometer was set
at 180 °C, and the spray voltage was maintained at 2.0
kV. The activation time was maintained at 30 ms using
an activation q value of 0.25. The isolation window was
maintained at 2.0 m/z while the normalized collision
energy was set at 35. All spectra were recorded in
centroid mode. The LTQ was operated in a data-
dependent constant neutral loss scan (DDCNL) mode
by performing CID-MS/MS scans on the three most
intense peaks from each MS scan, while simultaneously
searching for the defined neutral losses (Table 1). Here,
the neutral losses with m/z variance of 0.5 were set to
account for single, double, triple and quadruple
S(CH3)2 neutral losses from [M
N(m-N)H]m precur-
sor ions, where M represents the peptide, N represents
the number of modifications, and m represents the
different observed charge states ranging from2 to5.
If the targeted neutral loss was detected and appeared
above a predefined threshold abundance of 1.0  104
counts, CID-MS3 was automatically initiated to further
fragment the most intense neutral loss product ion.
Dynamic exclusion was enabled to analyze ions with the
selected data dependentm/z three times within 30 s before
it was placed on a dynamic exclusion list for a period of
10 s. Characterization of modification sites and peptide
sequences were determined manually from interpretation
of the MS3 spectra. The program GetArea [40] was used,with all parameters set at the default values, to calculate
the solvent-accessibilities of lysine amino acid side chains
and the N-terminal amino group of CRABP II, based on
the NMR solution structure of CRABP II.
Computational Methods
Model structures of the neutral and protonated side-
chain functional groups of lysine (methylamine), histi-
dine (4-methyl imidazole), and arginine (N-methyl gua-
nidine), as well as the side chain formed via the loss of
S(CH3)2 from the DMBNHS modified peptides (N-
methyl iminohydrofuran) were initially optimized at
the PM3 semi-empirical level of theory to identify likely
candidates for the global minimum, followed by further
optimization at the B3LYP/6-311G(d,p) level of the-
ory [41]. Single point calculations were then performed
at the MP2/6-311G(2d,p) level of theory. All opti-
mized structures were subjected to vibrational fre-
quency analysis at the B3LYP/6-311G(d,p) level. Pro-
ton affinities were calculated according to the negative
of the enthalpy of the protonation reaction, as described
previously [42].
Results and Discussion
Design of the DMBNHS Protein Modification
Reagent
The DMBNHS (1) reagent was specifically designed to
have favorable solution phase reactivity and gas-phase
fragmentation characteristics for application in a multi-
stage tandem mass spectrometry strategy for the ‘tar-
geted’ identification and characterization of modified
peptides, as described below and depicted in Scheme 1.
First, it has an NHS-ester moiety which enables the
reagent to react specifically in solution towards the
Table 1. Summary of the data dependant constant neutral loss
(DDCNL) MS/MS values employed for the identification of
DMBNHS modified Glu-C digest peptides from CRABP II
Neutral loss
(m/z)
Number of S(CH3)2
neutral losses Precursor ion
62.00 1 [MN] a
2 [MN(2-N)H]2 a
3 [MN(3-N)H]3 a
4 [MN(4-N)H]4 a
49.60 4 [MN(5-N)H]5 a
46.50 3 [MN(4-N)H]4 a
41.33 2 [MN(3-N)H]3 a
37.20 3 [MN(5-N)H]5 a
31.00 1 [MN(2-N)H]2 a
2 [MN(4-N)H]4 a
24.80 2 [MN(5-N)H]5 a
20.67 1 [MN(3-N)H]3 a
15.50 1 [MN(4-N)H]4 a
12.40 1 [MN(5-N)H]5 a
a N  number of modifications.-amino groups on lysine residue side chains and/or
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contains a sulfonium ion moiety, whose permanent
charge potentially enhances the ionization efficiency
[43], and which serves as an efficient leaving group to
facilitate the thermodynamically favored exclusive neu-
tral loss(es) of dimethylsulfide upon CID-MS/MS, in-
dependently of the amino acid composition and charge
state of the precursor peptide ion (i.e., proton mobility),
thereby allowing modified peptides to be readily iden-
tified from within a mixture of unmodified peptides,
i.e., ‘finding the needle in the haystack’. Furthermore,
the number of neutral losses observed in the MS/MS
spectrum is indicative of the number of modified resi-
dues within the peptide. The observation of the exclu-
sive neutral loss(es) can be used to automatically ‘trig-
ger’ the acquisition of an MS3 spectrum, in a data
dependant mode of operation, to facilitate subsequent
characterization of the peptide sequence and the site(s)
of modification. Finally, the five-membered cyclic imi-
nohydrofuran product that if formed via the loss of
dimethylsulfide during MS/MS is stable to dissociation
during subsequent CID-MS3, thereby allowing the pep-
tide sequence and the site(s) of modification to be
readily characterized.
CRABP II Modification by DMBNHS and HPLC-
ESI-MS Analysis of the Resultant Glu-C Digest
Peptides
The utility of the DMBNHS based protein modification
Scheme 1. Schematic of the solution phase DMBNHS (1) protein
modification and gas-phase CID-MS/MS and -MS3 fragmentation
reactions of DMBNHS modified peptide ions.and ‘targeted’ multistage tandem mass spectrometrystrategy for the identification and characterization of
modified peptides for mapping protein surface residue
accessibilities was demonstrated here using a model
protein, CRABP II. The complete sequence of CRABP II
is shown in Scheme 2, with the 13 lysine residues
distributed throughout the protein sequence and the
N-terminal residue labeled in bold text. The solvent-
accessibilities of these lysine amino acid side chains and
the N-terminal amino group, based on the previously
determined NMR solution structure of CRABP II [38],
are predicted to range from 26.0% to 93.1% (Table 2)
[40].
CRABP II was subjected to reaction with varying
amounts of DMBNHS, with reagent/protein ratio’s
ranging from 5 to 100. After 30 min, the modification
was quenched and the modified protein was digested
overnight with Glu-C before being subjected to HPLC-
MS, -MS/MS, and -MS3 analysis. No reduction or
subsequent alkylation was performed before protein
digestion in the current study, as there are no disulfide
bonds in the CRABP II protein sequence. However, we
have demonstrated in preliminary studies that the
sulfonium ion moieties contained within modified pro-
teins are stable (i.e., not lost or degraded) under typical
conditions employed for reduction of disulfide bonds
using tris(2-carboxyethyl)phosphine (TCEP) (data not
shown).
The base peak chromatograms obtained following
LC-MS of each of the labeled CRABP II Glu-C digests
are shown in Figure 1. The identities of the peaks in
each chromatogram (determined following interpreta-
tion of the MS/MS and MS3 spectra obtained from each
peak as discussed in detail below) are labeled in Figure
1, and summarized in Table 2. The observed peptides
represented 79% of the protein sequence and contained
all 13 lysine residues and the N-terminus. For each of
the peptides, it can be seen that the extent of modifica-
tion increases with increasing reagent to protein ratio,
albeit to different extents depending on the identity of
the peptide, indicating that each of the lysine residues
are exposed on the surface of the protein, which is
consistent with the known solution structure [38].
CID-MS/MS and -MS3 Analysis of Peptides
Formed by Glu-C Digestion of the DMBNHS
Modified CRABP II Protein
Following the acquisition of each MS scan, the three
most abundant precursor ions were automatically sub-
Scheme 2. Amino acid sequence of cellular retinoic acid binding
protein II (CRABP II). The DMBNHS modification sites are
indicated in bold text, while the Glu-C digestion sites are indicated
in italic text.
hase
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product ions were observed at m/z values correspond-
ing to the neutral loss of one or more dimethylsulfide
groups from a singly, doubly, triply or quadruply
modified precursor ion with a charge state ranging
from1 to5 (see Table 1), the most abundant of these
product ions was automatically isolated and subjected
to further dissociation by CID-MS3.
Figure 2 shows the CID-MS/MS and -MS3 spectra
acquired from peptide 1-13 (PNFSGNWKIIRSE), which
contains two modifiable residues, i.e., the secondary
amino group of the N-terminal proline residue and the
-amino of the lysine residue K8. Thus, it is expected
that two singly modified peptides (i.e., 1-131 (where the
superscript number indicates the modified residue) and
1-138, with the same mass but different modification
sites), and one doubly modified peptide (1-13(1,8) should
be observed. Figure 2a and b show the product ion
spectra obtained by CID-MS/MS of the triply charged
[1-1382H]3 and [1-1312H]3 precursor ions from
the peaks at approx. 19.8 min and 20.6 min in Figure 1.
It can be seen that both these MS/MS spectra are
identical, each giving rise to a single product ion via the
exclusive loss of dimethylsulfide (S(CH3)2). Similar re-
sults were obtained by dissociation of the doubly
charged ([1-138H]2 and [1-131H]2) precursor ions
(shown in the insets to Figure 2a and b). Notably, the
presence of a ‘mobile’ proton in the triply charged
precursor ions (the doubly charged precursor ions are
in a ‘non-mobile’ charge state) was observed to have no
effect on the MS/MS fragmentation reaction involving
the exclusive loss of S(CH3)2, consistent with previous
studies demonstrating that the selective dissociation of
sulfonium ion derivatized peptides occurs indepen-
dently of the proton mobility of the precursor ion, i.e.,
Table 2. Summary of observed CRABP II Glu-C digest peptide
amino acid solvent accessibilities
Peptide
residues Sequence
97-112 QKLLKGEGPKTSWTRE
63-70 INFKVGEE
47-62 GDTFYIKTSTTVRTTE
1-13 PNFSGNWKIIRSE
63-72 INFKVGEEFE
1-17 PNFSGNWKIIRSENFEE
63-96 INFKVGEEFEEQTVDGRPCKSLVKWESENKMVCE
18-42 LLKVLGVNVMLRKIAVAAASKPAVE
a Solvent accessibilities were predicted based on the known solution pthat ionizing protons simply act as ‘spectators’ ratherthan participating in competing fragmentation reac-
tions [28–33].
CID-MS3 of the [1-1382H-S(CH3)2]
3 and [1-13 1
2H-S(CH3)2]
3 product ions from Figure 2a and b gave
rise to the spectra shown in Figure 2c and d, respec-
tively. Interpretation of the spectra in Figure 2C re-
sulted in the assignment of a series of modified y6
†2,
y7
†2, y8
†2, y9
†2, y10
†2, y11
†2, and y12
†2 and un-
modified y4, b2, and b3 product ions, where a dagger (
†)
indicates sequence ions containing one modified resi-
due. These ions allowed the modification site to be
located at the K8 residue. In contrast, Figure 2D con-
tained a series of modified b-type product ions (b3
†, b5
†,
b6
†, b7
†, b8
†, b8
†2, b9
†2, b11
†3, and b12
†3) and a series
of unmodified y-type ions, allowing the site of the
modification to be localized to the P1 residue. CID-MS
3
of the [1-138H-S(CH3)2]
2 and [1-131H-S(CH3)2]
2
product ions from the insets shown in Figure 2a and b
resulted in the formation of a variety of y- and b-type
product ions, similar to those seen for the triply charged
product ions in Figure 2c and d (data not shown).
However, as the abundance of the doubly charged
precursor ions were significantly lower than those for
the triply charged precursors, the signal to noise for the
MS3 spectra were substantially lower.
Figure 3a and b show the CID-MS/MS product ion
spectra obtained from the doubly modified (1-131,8
peptide, in its doubly (i.e., [1-131,8]2) and triply (i.e.,
[1-131,8H]3) charged precursor ion charge states,
respectively. In each case, two characteristic neutral loss
product ions were observed, corresponding to the neu-
tral losses of one and two S(CH3)2 groups, indicative of
the presence of two modifications within the peptide.
Notably, for both spectra, product ions corresponding
to the neutral loss of two S(CH3)2 groups were signifi-
ences, retention time ranges, modifiable residues, and predicted
Retention time
range (min)
Modifiable
residues present
Predicted solvent
accessibilitiesa
11.51–13.93 K98 49.6
K101 72.7
K106 42.6
14.49–15.46 K66 60.5
15.54–16.71 K53 38.3
18.99–19.85 P1 57.8
K8 45.7
20.06–21.10 K66 60.5
22.04–23.61 P1 57.8
K8 45.7
23.94–25.20 K66 60.5
K82 28.1
K86 56.2
K92 26.0
29.25–31.94 K20 49.3
K30 58.1
K38 93.1
structure of CRABP II [38], by using the GetArea program [40].sequcantly more abundant than those corresponding to the
obser
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these product ions that were automatically selected for
further dissociation by MS3. As shown in Figure 3c, MS3
dissociation of the [1-131,8-2S(CH3)2H]
3 product ion
from Figure 3b allowed the expected modification sites
at the P1 and K8 residues to be readily assigned.
It is expected that the proton affinity of the imino-
hydrofuran containing functional group that is formed
following the loss of S(CH3)2 from a DMBNHS sulfo-
nium ion modified peptide would be higher than that of
an unmodified amino group. If so, this could potentially
result in a decreased ‘proton mobility’ within the
MS/MS product ion, and could thereby limit the extent
of sequence information that is obtained following MS3
for determination of the identity of the peptide and
localization of the site of the modification, compared
with that obtained from an unmodified peptide. Calcu-
lation of the proton affinity of the simplest model for
the iminohydrofuran containing functional group (i.e.,
N-methyl iminohydrofuran), at the MP2/6-311
G(2d,p)//B3LYP/6-311G(d,p) level of theory, re-
Figure 1. Base peak chromatograms of the Glu-C
modified with DMBNHS using (b) 5-fold, (c) 10-fo
Peaks are annotated as: X-Yn, where the X and Y in
superscript n indicates the residue(s) that is mo
isomeric forms of a given modified peptide weresulted in a proton affinity of 228.2 kcal mol1 (Supple-mental Table S1, which can be found in the electronic
version of this article). This value is 17.2 kcal mol1
higher than that calculated for the simplest model for
lysine (methylamine, 211.0 kcal mol1), and is interme-
diate between the calculated values for the simplest
models for histidine (4-methyl imidazole, 223.5 kcal
mol1) and arginine (N-methyl guanidine, 234.2 kcal
mol1), at the same level of theory. Despite this result,
a comparison of the MS3 product ion spectra obtained
from the modified 1-13 peptide ions (e.g., the [1-138-
S(CH3)22H]
3 and [1-131-S(CH3)22H]
3 ions in Fig-
ure 2c and d, and the [1-131,8-2S(CH3)2H]
3 ion in
Figure 3c, with the MS/MS spectra of the unmodified
1-13 peptide in the same charge state (i.e., the
[1-133H]3 ion) (Supplementary Figure S1), revealed
that the sequence coverage obtained following MS3 of
the modified peptide ions was equivalent to, or greater
than, that from the unmodified MS/MS spectrum.
Interestingly, the MS3 spectrum obtained from the
modified [1-138-S(CH3)22H]
3 product ion (K8 modi-
fied) was very similar to that obtained by MS/MS of the
sts from (a) unmodified CRABP II and CRABP II
) 20-fold, (e) 50-fold, and (f) 100-fold molar excess.
e the residue numbers within the protein, and the
. A superscript forward slash (/) indicates that
ved within a single co-eluting peak.dige
ld, (d
dicat
difiedunmodified [1-133H]3 ion. This is consistent with the
1346 ZHOU ET AL. J Am Soc Mass Spectrom 2010, 21, 1339–1351expected sites of proton localization in both peptides
being at the arginine, lysine (or iminohydrofuran) and
N-terminal residues (considered to be ‘non-mobile’,
‘partially mobile’, and ‘mobile’, respectively). In con-
trast, the MS3 spectra from the modified [1-131-
S(CH3)22H]
3 product ion (P1 modified) and the
[1-131,8-2S(CH3)2H]
3 product ion (P1 and K8 modi-
fied) were substantially different to the MS/MS spec-
trum from the unmodified peptide, presumably due to
differences in the site(s) of protonation or the decreased
proton mobility of the N-terminal within these peptides
(a protonated iminohydrofuran moiety located at the
N-terminal residue of the modified peptide would be
expected to result in a ‘partially mobile’ rather than
Figure 2. Multistage MSn (CID-MS/MS and -M
II peptides PNFSGNWKIIRSE (1-138) and PN
charged (a) [1-1382H]3 and (b) [1-1312H]3
CID-MS/MS spectra from the doubly charged [
tively. CID-MS3 of (C) the [1-1382H-S(CH3)2
S(CH3)2]
3 product ion from (b). A superscrip
modified amino acid residue. A superscript ast
circle] indicates the loss of H2O. A superscript
indicates an unmodified sequence ion was ob
observed with one modified amino acid.‘mobile’ proton).The results obtained following CID-MS/MS and
-MS3 of the modified forms of peptide 18-42, (LLKVL-
GVNVMLRKIAVAAASKPAVE) containing three ly-
sine residues (resulting in the potential formation of
three singly modified peptides (18-4220, 18-4230 and
18-4238, three doubly modified peptides (18-4220,30, 18-
4220,38 and 18-4230,38 and one triply modified peptide
(18-4220,30,38), further demonstrates the utility of the
sulfonium ion derivatization approach for the ‘targeted’
identification and characterization of modified peptide
ions. As shown in Figure 1, two singly modified forms
of the 18-42 peptide were observed. As expected, CID-
MS/MS of the triply charged [18-42382H]3 and [18-
42302H]3 precursor ions were identical, each giving
the isomeric DMBNHS singly modified CRABP
WKIIRSE (1-131). CID-MS/MS of the triply
ursor ions. The insets to (a) and (b) show the
H]2 and [1-131H]2 precursor ions, respec-
roduct ion from (a), and (d) the [1-1312H-
ger (†) indicates sequence ions containing one
indicates the loss of NH3. A superscript [open
) indicates the addition of H2O. A dashed line
d. A solid line indicates a sequence ion wasS3) of
FSGN
prec
1-138
]3 p
t dag
erisk
dot (•
serverise to the exclusive neutral loss of a single S(CH3)2
ds.
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obtained by dissociation of the [18-42382H-S(CH3)2]
3
and [18-42302H-S(CH3)2]
3 product ions, the modifi-
cation sites were located on the K38 residue for the
18-4238 form of the peptide (Figure 4a), and on the K30
residue for the 18-4230 form of the peptide (Figure 4b).
No evidence was found for a form of the 18-42 peptide
that was singly modified at the K20 residue, suggesting
that this residue was less reactive to the DMBNHS
reagent (i.e., less accessible) compared with the adjacent
K30 and K38 residues (see the section below for further
discussion).
CID-MS/MS of the quadruply charged precursor
ions of the three doubly modified 18-42 peptide ions
(the 18-42 20,38 peak was separately resolved while the
18-4220,30 and 18-4230,38 peaks were closely eluting) each
resulted in the exclusive loss of up to two S(CH3)2
groups, similar to that described above for the 1-13
peptide, indicating the presence of two modifications
within the peptides (data not shown). Once again, the
loss of two S(CH3)2 groups was the dominant fragmen-
tation pathway. The MS3 spectra shown in Figure 5
Figure 3. Multistage MSn (CID-MS/MS and -
peptide PNFSGNWKIIRSE (1-131,8). CID-MS/M
charged ([1-131,8H]3) precursor ions. CID-MS
(b). A superscript dagger (†) indicates sequence
superscript double dagger (‡) indicates sequence
A superscript open circle indicates the loss of H2
dashed line indicates an unmodified sequence
sequence ion was observed with one modified a
ion was observed with two modified amino aciwere used to assign the sites of modification to the K20and K38 residues for the 18-42
20,38 peptide (Figure 5a),
the K20 and K30 residues for the 18-42
20,30 peptide
(Figure 5b), and the K30 and K38 residues for the
18-4230,38 peptide (Figure 5c). Because the 18-4220,30 and
18-4230,38 peptides were not well resolved, several of the
ions from the 18-4220,30 peptide (e.g., b16
‡2, b17
‡2, and
b18
‡2) were also observed in the spectrum from the
18-4230,38 peptide.
Finally, Supplemental Figure S2 shows the CID-
MS/MS and -MS3 spectra of the quadruply charged
precursor ion of the triply modified 18-4220,30,38 peptide.
MS/MS resulted in the characteristic neutral loss of up
to three S(CH3)2 groups, indicating the presence of three
modifications within the peptide, while MS3 confirmed
the identity of the peptide sequence and localization of
the modifications on each of the three lysine residues,
K20, K30, and K38. For comparison of the sequence
coverage obtained from each of the singly, doubly and
triply modified forms of the 18-42 peptide ions, Supple-
mental Figure S3 shows the CID-MS/MS spectra from
the triply and quadruply protonated precursor ions of
the unmodified 18-42 peptide, while the results ob-
of the DMBNHS doubly modified CRABP II
a) the doubly charged ([1-131,8]2) and (b) triply
c) the [1-131,8H-2S(CH3)2]
3 product ion from
containing one modified amino acid residue. A
containing two modified amino acid residues.
superscript (•) indicates the addition of H2O. A
was observed. A single solid line indicates a
acid. A double solid line indicates a sequenceMS3)
S of (
3 of (
ions
ions
O. A
ion
minotained by MS/MS or CID-MS3 of the unmodified and
1348 ZHOU ET AL. J Am Soc Mass Spectrom 2010, 21, 1339–1351modified forms, respectively, of the remaining peptides
in Figure 1 (97-112, 63-70, 63-72, 47-62, and 1-17) are
shown in Supplemental Figures S4–S15.
Correlation of the Modified Peptide Ion
Abundances with the Predicted Solvent
Accessibilities of CRABP II
Normalized plots of the relative abundances (summed
from all observed charge states) of the unmodified,
singly modified, doubly modified, and triply modified
peptides versus the stoichiometric ratios of DMBNHS
reagent to protein are shown in Figure 6. These plots
summarize the reactivity of the peptides towards
DMBNHS and therefore are indicative of the solvent
accessibility of these peptide regions. The experimen-
tally determined solvent accessibilities of the lysine
residues in these peptide regions were also compared
with the calculated solvent accessibilities, determined
using the GetArea program [40] (see Table 2) based on
the known NMR solution phase structure of CRABP II.
The results are discussed in detail below. Note that the
plots shown herein were generated assuming that the
ionization efficiency of a given peptide was not affected
by the DMBNHS modification, even though potential
Figure 4. CID-MS3 of the triply charged pro
DMBNHS singly modified CRABP II peptides
LLKVLGVNVMLRKIAVAAASKPAVE (18-4230)
ion. (b) CID-MS3 of the [18-42302H-S(CH3)2]
sequence ions containing one modified amino a
sequence ion was observed. A single solid lin
modified amino acid.enhancement of the ionization efficiencies caused by theincorporation of the sulfonium ion may occur [43]. Also,
it was assumed that the magnitude of any enhancement
in ionization efficiencies would be similar between
peptides, and would therefore not have an impact on
determination of the relative solvent accessibilities. Fur-
thermore, the consistency of our results with the pre-
dicted solvent accessibilities of the CRABP II lysine
residues (see below) suggest that any differences
caused by ionization efficiency are not substantial.
Peptides 47-62 (Figure 6a) and 63-70 (Figure 6b) each
contain only one lysine residue, K53 and K66, respec-
tively. The peak relative abundance of the singly mod-
ified 63-70 peptide (64%  1%) was higher than that of
the 47-62 peptide (58%  3%). These data suggest that
K66 is more accessible to the DMBNHS reagent com-
pared with K53. This result is consistent with the
GetArea predicted solvent accessibilities of these resi-
dues (60.5% for K66 and 38.3% for K53).
Peptides 1-13 and 1-17 contain two identical modifi-
able residues, P1 (N-terminus) and K8, so their re-
sponses to an increasing amount of modification re-
agent were expected to be the same. However, 1-13
(Figure 6c) showed a higher extent of modification than
1-17 (Figure 6d). This might be due to a difference in the
extent of ionization efficiency between the unmodified
ions formed by CID-MS/MS of the isomeric
LGVNVMLRKIAVAAASKPAVE (18-4238) and
ID-MS3 of the [18-42382H-S(CH3)2]
3 product
oduct ion. A superscript dagger (†) indicates
esidue. A dashed line indicates an unmodified
icates a sequence ion was observed with oneduct
LLKV
. (a) C
3 pr
cid r
e indand modified forms between the two peptides, or a
ds.
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by the modification (i.e., the incorporation of the fixed
charge may enhance enzymatic cleavage at the cleav-
able site closest to the modification). The predicted
solvent accessibilities of the P1 and K8 residues are
57.8% and 45.7%, respectively. However, for both the
1-13 and 1-17 peptides, the abundance of the K8 modi-
fied peak (e.g., [1-138] in Figure 1 was higher than that
of the P1 modified peak (e.g., [1-13
1 in Figure 1]). This is
rationalized as being due to differences in the rate of
reactivity between the primary -amino group of the
lysine side chain and the secondary amine functional
group of the N-terminal proline residue, respectively,
toward the NHS ester of the DMBNHS reagent.
Both peptides 97-112 and 18-42 contain three lysine
residues. The triply modified 18-42 peptide was ob-
served with a maximum relative abundance of 57% 
5%, while the triply modified 97-112 peptide was ob-
served with a maximum relative abundance of only
Figure 5. CID-MS3 of the quadruply charged p
DMBNHS doubly modified CRABP II peptides
LLKVLGVNVMLRKIAVAAASKPAVE (18-4220,
4230,38). (a) CID-MS3 of the [18-4220,382H-2S
4220,302H-2S(CH3)2]
4 product ion. (c) CID-M
superscript dagger (†) indicates sequence ions
superscript double dagger (‡) indicates sequence
A dashed line indicates an unmodified sequen
sequence ion was observed with one modified a
ion was observed with two modified amino aci28%  1% (compare Figure 6e and f, respectively). Thisoverall greater extent of reaction of the 18-42 peptide
compared with the 97-112 peptide is consistent with the
higher summed predicted solvent accessibilities of the
K20 (49.3%), K30 (58.1%) and K38 (93.1%) residues
(summed total of 200.5%) versus the K98 (49.6%), K101
(72.7%) and K106 (42.6%) residues (summed total of
164.9%). Also consistent with the predicted solvent
accessibilities, which suggest that K38 is the most ex-
posed residue followed by K30 and finally K20, the
intensity of the 18-4238 modified peptide was found to
be more abundant than the 18-4230 modified peptide.
Finally, the lack of a singly modified 18-4220 peak
corresponding to modification at the K20 residue is
consistent with its significantly lower predicted solvent
accessibility compared with the K30 and K38 residues.
Unfortunately, the isomeric singly and doubly modified
forms of the 97-112 peptide were not chromatographi-
cally resolved. As a result, the predicted solvent acces-
sibilities of each lysine residue could not be correlated
ct ions formed by CID-MS/MS of the isomeric
VLGVNVMLRKIAVAAASKPAVE (18-4220,38),
nd LLKVLGVNVMLRKIAVAAASKPAVE (18-
3)2]
4 product ion. (b) CID-MS3 of the [18-
the [18-4230,382H-2S(CH3)2]
4 product ion. A
taining one modified amino acid residue. A
containing two modified amino acid residues.
was observed. A single solid line indicates a
acid. A double solid line indicates a sequencerodu
LLK
30), a
(CH
S3 of
con
ions
ce ion
minowith their reactivity. Similarly, the singly, doubly, triply
own
1350 ZHOU ET AL. J Am Soc Mass Spectrom 2010, 21, 1339–1351and quadruply modified forms of the 63-96 peptide
containing four modifiable sites (K66, K82, K86, and K92)
were not chromatographically resolved, precluding the
ability to correlate their individual reactivity and pre-
dicted solvent accessibility. Overall however, the results
described above provide strong evidence that the extent
of modification of the DMBNHS reagent is correlated
with the protein solvent accessibility.
Conclusions
The results presented herein describe (1) the synthesis
of an amine reactive sulfonium ion containing protein
modification reagent, DMBNHS, (2) the development of
an automated ‘targeted’ multistage tandem mass spec-
trometry strategy for the identification and character-
ization of protein surface accessible residues, and (3) its
initial application to a model protein, CRABP II.
DMBNHS modified peptides give rise to exclusive
neutral loss product ions upon CID-MS/MS, allowing
the selective identification of modified peptides and
determination of the number of modifications. Subse-
quent data dependant MS3 of these neutral loss product
ions readily enables characterization of the peptide
sequence and localization of the modification site(s). Fur-
thermore, the reactivity of individual residues within the
modified peptides is correlated with their predicted sol-
vent accessibilities. The initial success of this experimental
strategy, i.e., combing protein modification by DMBNHS
R
el
at
iv
e 
A
bu
nd
an
ce
 (%
)
Reagent/Pro
100
20
40
60
80
100
20
40
60
80
100
20
40
60
80
020 40 60 80
C (1-1
A (47-6
E (18-4
Figure 6. Plots of the relative abundances of
peptides (dashed line), doubly modified peptide
and dotted line) versus the molar ratios of reage
(c) peptide 1-13, (d) peptide 1–17, (e) peptide 18
prepared and run in triplicate. Error bars are shwith data dependant multistage tandem mass spectrom-etry, provides confidence for its application in future
studies involving the examination of protein structure in
larger proteins, as well as for the study of protein-protein
and protein-ligand interactions.
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